This is a new core facility established at the request of the Cancer Center membership at the 1998 leadership retreat. The Cancer Center Executive Committee recommended that we enter into a partnership with the Doheny Eye Institute to jointly purchase a 5th generation confocal microscope to be housed in their space under the direction of Dr. Hinton. The Doheny Eye Institute is located next door to the Norris building which gives members easy access to an already functional facility containing an existing older back-up confocal microscope. The Center committed $250,000 of philanthropic funds to the new instrument and expects to utilize the joint facility approximately 50% of the time. The Executive Committee felt that this approach would give the membership immediate access to state-of-the-art imaging. Also located within the 2,000 square foot core facility, in addition to the two confocals, are the following shared instruments whose use is charged back to investigators on a cost recovery basis: one transmission electron microscope (Zeiss EM-10B), one scanning electron microscope with digital capture and computer workstation (Hitachi S-570), three ultra microtomes, three darkrooms for developing, printing and autoradiography, a photomicroscopy and photomicrography imaging suite complete with a Spot II digital camera and computer imaging system adapted to two Olympus Microphot scopes with Nomarski and phase optics, one Olympus inverted microscope with fluorescence and phase optics, one Zeiss fluorescence microscope with phase, darkfield, and differential interference contrast optics, and digital camera copy stand. Other equipment located in the facility includes a vacuum evaporator, sputter coater, critical point dryer, two print processors, three enlargers, two print and film dryers, two dissecting microscopes, a tissue cryostat, tissue chopper, several computer workstations, a Polaroid slide maker, a color laser printer and a slide scanner. The Confocal Core Facility is currently operating at 90% capacity and has proved to be an invaluable resource for over 20 cancer center members in a wide range of programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA014089-27S1
Application #
6577731
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-04-02
Project End
2002-11-30
Budget Start
Budget End
Support Year
27
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Schaal, Justin B; Maretzky, Thorsten; Tran, Dat Q et al. (2018) Macrocyclic ?-defensins suppress tumor necrosis factor-? (TNF-?) shedding by inhibition of TNF-?-converting enzyme. J Biol Chem 293:2725-2734
Iriondo, Oihana; Liu, Yarong; Lee, Grace et al. (2018) TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis. Nat Commun 9:1994
Robison, Nathan J; Yeo, Kee Kiat; Berliner, Adrian P et al. (2018) Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors. J Neurooncol 138:199-207
Naseem, Madiha; Barzi, Afsaneh; Brezden-Masley, Christine et al. (2018) Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 66:15-22
Sebio, A; Stintzing, S; Heinemann, V et al. (2018) A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials. Pharmacogenomics J 18:43-48
Peres, Lauren C; Risch, Harvey; Terry, Kathryn L et al. (2018) Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. Int J Epidemiol 47:460-472
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Zhao, Yi; Wu, Kaijin; Wu, Yongfeng et al. (2018) Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists. Curr Mol Pharmacol 11:113-121
Kahn, Michael (2018) Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators. Prog Mol Biol Transl Sci 153:209-244

Showing the most recent 10 out of 842 publications